Puig Targets €8 Billion in Revenue by 2032 With Isdin Deal

Puig has set a target of exceeding €8 billion in annual net revenues by 2032, alongside an adjusted EBITDA margin above 22.5% and status as a top-four premium beauty company and top-two fragrance player. CEO Jose Manuel Albesa unveiled the plan, branded 'Vision 2032', at the company's Capital Markets Day 2026 in Madrid on 28 October. The company passed €5 billion in net revenues in 2025, having more than tripled revenue over five years.

The plan rests almost entirely on organic growth. "'Vision 2032' is our plan to scale what works, profitably," Albesa said. He added that Puig expects to deliver the ambition "primarily through organic growth, driven by reinforcing our core portfolio, scaling our strongest brands, and concentrating our resources on the categories, markets and channels where we have the clearest opportunity to win." Selective acquisitions will complement, not drive, the strategy. What the company did not quantify is how much of the gap between €5 billion and €8 billion comes from the already-announced Isdin transaction versus underlying brand growth.

What does Vision 2032 change across the portfolio?

The strategy concentrates on four areas: prestige fragrances, niche fragrances, the make-up brand Charlotte Tilbury, and dermocosmetics.

In prestige fragrances, Puig's clearest gap is feminine perfumes. These account for roughly 65% of the global prestige fragrance market but only about 45% of Puig's prestige fragrance business. The company plans to develop Carolina Herrera as a two-axis brand, growing both its perfume range and its make-up presence. Rabanne and Jean Paul Gaultier will expand through what a company statement called "disruptive innovation and culturally relevant global activation."

Niche fragrances, Puig's fastest-growing division, will scale through Byredo and Penhaligon's, with selective expansion in the US and Asia. Puig stated this growth will come while "preserving exclusivity and profitability" — a hedge the company offered without specifying how it will measure that balance.

Charlotte Tilbury has more than tripled in size since Puig acquired it in 2020. Puig now aims to multiply the brand's business x1.5 by 2032 through make-up growth, an accelerated skin-care focus, fragrance innovation slated for 2028, and selective distribution expansion.

How large will the dermocosmetics platform become?

Dermocosmetics, the category most relevant to clinical readers, receives the plan's most concrete structural move. Puig has agreed a deal with Corporación Químico-Farmacéutica Esteve (CQFE) to take full ownership of the skin care brand Isdin. Isdin generated approximately €650 million in revenues in 2025. The transaction is expected to complete in Q1 2027, subject to regulatory approvals.

On completion, Isdin, the French dermocosmetic brand Uriage and the Greek natural skin and hair care brand Apivita would form a dermocosmetics platform with more than €1 billion in pro forma net revenues. Separately, Puig aims to double Uriage's sales by 2032 through category, geographic, e-commerce and channel expansion, including specialist beauty, department stores, travel retail and digital platforms.

Which white spaces does Puig identify?

Puig listed six growth "white spaces" it defines as sitting at the intersection of brand and market priorities:

• Digital: strengthening omnichannel and pure-player partnerships, with selective expansion across marketplaces, social commerce and Puig's own e-commerce platforms.
• Asia-Pacific: scaling niche fragrances and Charlotte Tilbury in North East Asia; prestige fragrances and dermocosmetics across South East Asia, India and Oceania.
• US niche fragrances: expanding Byredo and Penhaligon's in a market that represents 25% of the global niche segment.
• Feminine prestige fragrances: building on Good Girl, La Bomba and the 2026 launch of Jean Paul Gaultier's La Favorite.
• Charlotte Tilbury distribution: selective expansion in existing and new markets while protecting distribution quality and brand equity.
• Dermocosmetics: entering new markets and channels across specialist beauty, department stores, travel retail and digital.

What track record supports the targets?

Puig bases Vision 2032 on its record as the fastest-growing multi-brand premium beauty company of the past five years, with consistent share gains across fragrances, make-up and skin care. In travel retail, the company has moved from the sixth to the third-largest fragrance player since 2021, lifting market share from 9.6% to 13.0%. An integrated operating model built around global brands, markets and functions, plus regional reinforcement of EMEA, LATAM and travel retail strongholds, is intended to unlock North America and APAC.

Executive Chairman Marc Puig framed the ambition as continuity rather than reinvention. "Puig enters this next chapter from a position of strength," he said. "Today, we are stronger than at any point in our over 110-year history." Whether a roughly 60% revenue increase in six years holds against a decelerating premium beauty market will depend on execution the plan itself acknowledges as selective rather than broad — the Isdin platform closing on schedule in Q1 2027 is the first measurable checkpoint.